1493 related articles for article (PubMed ID: 27122660)
21. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
Nakajima T; Naito H
Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
[TBL] [Abstract][Full Text] [Related]
22. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
23. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
[TBL] [Abstract][Full Text] [Related]
24. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.
Rosato V; Masarone M; Dallio M; Federico A; Aglitti A; Persico M
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31540048
[TBL] [Abstract][Full Text] [Related]
25. [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].
Halmos T; Suba I
Orv Hetil; 2017 Dec; 158(52):2051-2061. PubMed ID: 29285942
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
27. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
Williams T
FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
[TBL] [Abstract][Full Text] [Related]
28. [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents].
Smolka V; Ehrmann J; Tkachyk O; Zápalka M
Cas Lek Cesk; 2014; 153(2):91-7. PubMed ID: 24797780
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
Saponaro C; Gaggini M; Gastaldelli A
Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
32. Comorbidities and Metabolic Derangement of NAFLD.
Bang KB; Cho YK
J Lifestyle Med; 2015 Mar; 5(1):7-13. PubMed ID: 26528424
[TBL] [Abstract][Full Text] [Related]
33. What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa?
Tarantino G; Citro V; Finelli C
J Gastrointestin Liver Dis; 2014 Sep; 23(3):291-9. PubMed ID: 25267958
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Fatty Liver Disease and Liver Transplantation.
Pham T; Dick TB; Charlton MR
Clin Liver Dis; 2016 May; 20(2):403-17. PubMed ID: 27063277
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
Seto WK; Yuen MF
J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
[TBL] [Abstract][Full Text] [Related]
36. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
[TBL] [Abstract][Full Text] [Related]
37. Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.
Potze W; Siddiqui MS; Sanyal AJ
Semin Thromb Hemost; 2015 Jul; 41(5):488-93. PubMed ID: 26049073
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H
Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688
[TBL] [Abstract][Full Text] [Related]
39. A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
Targher G; Byrne CD
Metab Syndr Relat Disord; 2015 Aug; 13(6):235-8. PubMed ID: 25714786
[TBL] [Abstract][Full Text] [Related]
40. [Nonalcoholic fatty liver disease as a risk factor of macroangiopahty in patients with type 2 diabetes].
Trojak A; Idzior-Waluś B
Przegl Lek; 2012; 69(12):1276-9. PubMed ID: 23750438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
